Hi Attitudes, Mak has more than likely got a good point here (Mak and I have been discussing 'inside info' for almost a decade lol). It's interesting for perspective to re-visit a thread from January 2014 (almost 4 years ago) where we had almost identical discussions....time loop.........Knowledge IS power:
'OBJ has made it very clear that they are currently negotiating Product Licensing Agreements with both P&G & Coty. Also, Phase II Analgesic Study Agreement with OBJ following the successful completion of a Phase 1 program conducted during 2012 & Bodyguard progress......surely OBJ is worth it's current market cap & then some?!? 'Inside Info' - nonsense! More like a Zombie market that is beginning to awaken!'
https://hotcopper.com.au/threads/two-week-cycles.2170529/page-47?post_id=12874138#.We0y41uCze4
That whole thread is a fascinating re-read, where we now obviously know that almost 4 years later COTY & GSK still have not committed via a PDA/MLA, BodyGuard seems to be still plodding along nicely and the Revenues from the initial MicroArray PDA/MLA are only just now predicted to begin to ramp up for the coming Quarters; but also may not be sustainable as highlighted in the recent Investor Conference Call, as P&G also begin the migration from First Generation products to Second Generation/Integrated products. The end result will no doubt be the result we have all wanted; but definately has been a slow grind and it appears this slow grind will continue to be so for a while.
In 2014 there was so much unknown information that Shareholders and the Market in general had no choice but to speculate, which was no doubt imo why we witnessed the rise from 3's to 13 cents. The Market then seemed to like speculating across most sectors and still does to some extent. The difference here imo is that in almost 4 years, OBJ have generated very minimal Revenues over this almost 4 year period; and when Personalisation is locked into a PDA/MLA (remembering it took an additional 2.5 years for P&G to sign the MLA after the MicroArray PDA was announced in April 2014 - I'm optimistic the Personalisation PDA/MLA will be much quicker this time around); we now already know what the Personalisation second phase Milestone/Standstill Royalty income will be in the vicinity of a further 'approx. $1m':
View attachment 787398
http://www.asx.com.au/asxpdf/20170524/pdf/43jgpclc7hls20.pdf
And we now also know that OBJ, probably with the help of our Negotiator Dr Steve Mellor, have had the foresight this time around to include a 'termination' policy:
2nd tech licence -
Master Licencing Agreement - aim to get done before AGM, but dependent on P&G
They must give us launch plans with intentions next 18 months
And must have products on shelves within 30 months, or we have right to terminate
Provisions in there that allow us to move forward
Will take a full year to get product out
1000 person trial (considerable)
Very exciting for company.
So what exactly does all of this tell the Market this time around? Interim income relating to Phase II Personalisation for Milestone/Standstill Royalties will be around one million initially and we may not see products/royalties relating to Personalisation for quite some time. P&G move at their own pace, conduct large consumer trials and test their markets vigorously before Innovation Technology Partners/Company's like OBJ realise tangible revenue streams; as you would expect as in all reality - this IS P&G's Market after-all. Shareholders and the market Know and have alot more Knowledge this time around, which is refreshing and well-overdue; so I'm personally not expecting the same Market reaction as received when the P&G MicroArray PDA was announced back in April 2014. It's not down-ramping or a loss of faith in OBJ, but rather a more rounded and realistic measure for basing one's expectations moving forward.
Time-frames continue to be an OBJ nemesis, but ultimately Shareholders and the Market will be placated with the Global adoption of OBJ's tech being effectively rolled out via Integrated Products, with further distribution & market penetration and additional product Revenues via Personalisation. The final visualised whole picture for OBJ is a beautiful one imo, with the dream anticipated Integrated products on their way, but perhaps the Market may come to some similar conclusions in relation to time-frames this time around.
(20min delay)